Qube Research & Technologies Ltd - SPECTRUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$61,557
+1227.8%
64,122
+409.6%
0.00%
Q4 2022$4,636
-91.3%
12,582
-89.9%
0.00%
Q3 2022$53,000
-56.2%
124,369
-19.6%
0.00%
-100.0%
Q2 2022$121,000
+116.1%
154,597
+250.3%
0.00%
Q4 2021$56,000
-82.3%
44,132
-47.6%
0.00%
-100.0%
Q2 2021$316,000
+496.2%
84,158
+446.5%
0.00%
+300.0%
Q4 2020$53,000
-75.5%
15,400
-71.0%
0.00%
-66.7%
Q3 2020$216,00053,0220.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,963,756$145,960,0009.42%
Avoro Capital Advisors LLC 3,419,818$71,679,0002.76%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 300,000$6,285,0002.41%
Cormorant Asset Management, LP 1,200,000$25,152,0001.86%
Sio Capital Management, LLC 143,550$3,009,0001.66%
ASHFORD CAPITAL MANAGEMENT INC 425,702$8,923,0001.18%
PURA VIDA INVESTMENTS, LLC 130,700$2,739,0001.10%
Sonora Investment Management, LLC 298,967$6,266,0000.97%
PURA VIDA INVESTMENTS, LLC 100,000$2,096,0000.84%
J. Goldman & Co LP 694,338$14,553,0000.75%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders